![]() Back to Annual Meeting
|
|
![]() Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Madonna Murphy, MSc, PhD (c), Reza Alaghehbandan, MD, Don MacDonald, MSc, PhD (c), and Kayla Collins, MSc, PhD (c). Research and Evaluation Department, Centre for Health Information, 28 Pippy Place, St. John's, NF A1B 3X4, Canada, (709) 752-6037, donnam@nlchi.nl.ca
Objective: The objective of this study was to investigate epidemiologic characteristics of stillbirth in the province of Newfoundland and Labrador (NL), Canada.
Methods: A population-based study including all stillbirths to mothers resident in NL between 1995 and 2005 was conducted using the Stillbirth database and the Live Birth System. Annual rates of stillbirth by baby's gender, place of residence, mother's age, and season were calculated.
Results: During the study period, 286 stillbirths were recorded in NL, representing an overall stillbirth rate of 5.2 per 1,000 births (95% CI: 4.63-5.84). The stillbirth rates fluctuated over the 11-year study period (P > 0.05). Males had a higher rate of stillbirth than females (5.8 vs. 4.5 per 1,000 births, P = 0.05). The central health region of Newfoundland had the highest rate of stillbirth (7.9 per 1,000 births) and that was higher than the provincial rate (P < 0.0001). Mothers < 20 years of age had the highest rate of stillbirth (7.8 per 1,000 births) followed by age group > 34 years (5.9 per 1,000 births). Fetal asphyxia and placental separation/hemorrhage were the most common medical conditions associated with stillbirth. The rate of stillbirth was higher in spring (6.3 per 1,000 births) than other seasons.
Conclusion: This study highlights epidemiologic features, geographic disparities and groups at greater risk of stillbirth in the province. The findings can play a role in reducing the incidence of stillbirth in the province.
Learning Objectives:
Keywords: Epidemiology, Maternal Health
Related Web page: www.nlchi.nl.ca
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA